Residual Scope: Therapeutic Effects of Intranasally-Administered insulin (INI) in Adults with Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimers Disease (AD)

Grants and Contracts Details


To examine the effects of intranasally-administered insulin (INI) on cognition, entorhinal cortex and hippocampal atrophy, and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment (aMCI) or probable mild Alzheimer’s disease (AD)
Effective start/end date8/21/156/30/17


  • University of Southern California


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.